111 related articles for article (PubMed ID: 19286306)
21. Designed FHIT alleles establish that Fhit-induced apoptosis in cancer cells is limited by substrate binding.
Trapasso F; Krakowiak A; Cesari R; Arkles J; Yendamuri S; Ishii H; Vecchione A; Kuroki T; Bieganowski P; Pace HC; Huebner K; Croce CM; Brenner C
Proc Natl Acad Sci U S A; 2003 Feb; 100(4):1592-7. PubMed ID: 12574506
[TBL] [Abstract][Full Text] [Related]
22. Synergistic tumor suppression by coexpression of FHIT and p53 coincides with FHIT-mediated MDM2 inactivation and p53 stabilization in human non-small cell lung cancer cells.
Nishizaki M; Sasaki J; Fang B; Atkinson EN; Minna JD; Roth JA; Ji L
Cancer Res; 2004 Aug; 64(16):5745-52. PubMed ID: 15313915
[TBL] [Abstract][Full Text] [Related]
23. Relationship of protoporphyrin IX synthesis to photodynamic effects by 5-aminolaevulinic acid and its esters on various cell lines derived from the skin.
Lee JB; Choi JY; Chun JS; Yun SJ; Lee SC; Oh J; Park HR
Br J Dermatol; 2008 Jul; 159(1):61-7. PubMed ID: 18489589
[TBL] [Abstract][Full Text] [Related]
24. Engineering human Fhit, a diadenosine triphosphate hydrolase, into an efficient dinucleoside polyphosphate synthase.
Huang K; Frey PA
J Am Chem Soc; 2004 Aug; 126(31):9548-9. PubMed ID: 15291552
[TBL] [Abstract][Full Text] [Related]
25. Fhit expression protects against HER2-driven breast tumor development: unraveling the molecular interconnections.
Bianchi F; Tagliabue E; Ménard S; Campiglio M
Cell Cycle; 2007 Mar; 6(6):643-6. PubMed ID: 17374991
[TBL] [Abstract][Full Text] [Related]
26. Protoporphyrin IX-gold nanoparticle conjugates as an efficient photosensitizer in cervical cancer therapy.
Eshghi H; Sazgarnia A; Rahimizadeh M; Attaran N; Bakavoli M; Soudmand S
Photodiagnosis Photodyn Ther; 2013 Sep; 10(3):304-12. PubMed ID: 23993857
[TBL] [Abstract][Full Text] [Related]
27. Activation state-dependent interaction between Gαq subunits and the Fhit tumor suppressor.
Zuo H; Chan GP; Zhu J; Yeung WW; Chan AS; Ammer H; Wong YH
Cell Commun Signal; 2013 Aug; 11():59. PubMed ID: 23947369
[TBL] [Abstract][Full Text] [Related]
28. Effect of inducible FHIT and p53 expression in the Calu-1 lung cancer cell line.
Cavazzoni A; Galetti M; Fumarola C; Alfieri RR; Roz L; Andriani F; Carbognani P; Rusca M; Sozzi G; Petronini PG
Cancer Lett; 2007 Feb; 246(1-2):69-81. PubMed ID: 16616810
[TBL] [Abstract][Full Text] [Related]
29. FHIT alterations in breast cancer.
Ingvarsson S
Semin Cancer Biol; 2001 Oct; 11(5):361-6. PubMed ID: 11562178
[TBL] [Abstract][Full Text] [Related]
30. Ubc9-induced inhibition of diadenosine triphosphate hydrolase activity of the putative tumor suppressor protein Fhit.
Golebiowski F; Szulc A; Szutowicz A; Pawelczyk T
Arch Biochem Biophys; 2004 Aug; 428(2):160-4. PubMed ID: 15246872
[TBL] [Abstract][Full Text] [Related]
31. In vitro photodynamic therapy of cervical cancer.
Wołuń-Cholewa M; Piedel B
Ginekol Pol; 2011 Jul; 82(7):503-7. PubMed ID: 21913427
[TBL] [Abstract][Full Text] [Related]
32. A Fhit-ing role in the DNA damage checkpoint response.
Ishii H; Wang Y; Huebner K
Cell Cycle; 2007 May; 6(9):1044-8. PubMed ID: 17457056
[TBL] [Abstract][Full Text] [Related]
33. Small-Molecule Inhibitors of the Tumor Suppressor Fhit.
Lange S; Hacker SM; Schmid P; Scheffner M; Marx A
Chembiochem; 2017 Sep; 18(17):1707-1711. PubMed ID: 28643453
[TBL] [Abstract][Full Text] [Related]
34. Comparison of protoporphyrin IX produced cell proliferation inhibition between human breast cancer MCF-7 and MDA-MB-231 cells.
Li L; Chen Y; Wang X; Feng X; Wang P; Liu Q
Pharmazie; 2014 Aug; 69(8):621-8. PubMed ID: 25158574
[TBL] [Abstract][Full Text] [Related]
35. Understanding the mechanisms of FHIT inactivation in cervical cancer for biomarker development.
Lea JS; Ashfaq R; Muneer S; Burbee DG; Miller DS; Minna JD; Muller CY
J Soc Gynecol Investig; 2004 Jul; 11(5):329-37. PubMed ID: 15219888
[TBL] [Abstract][Full Text] [Related]
36. Molecular genetic alterations of FHIT and p53 genes in benign and malignant thyroid gland lesions.
Pavelić K; Dedivitis RA; Kapitanović S; Cacev T; Guirado CR; Danić D; Radosević S; Brkić K; Pegan B; Krizanac S; Kusić Z; Spaventi S; Bura M
Mutat Res; 2006 Jul; 599(1-2):45-57. PubMed ID: 16698048
[TBL] [Abstract][Full Text] [Related]
37. Fragile histidine triad-mediated tumor suppression of lung cancer by targeting multiple components of the Ras/Rho GTPase molecular switch.
Jayachandran G; Sazaki J; Nishizaki M; Xu K; Girard L; Minna JD; Roth JA; Ji L
Cancer Res; 2007 Nov; 67(21):10379-88. PubMed ID: 17974981
[TBL] [Abstract][Full Text] [Related]
38. Inactivation of both FHIT and p53 cooperate in deregulating proliferation-related pathways in lung cancer.
Andriani F; Roz E; Caserini R; Conte D; Pastorino U; Sozzi G; Roz L
J Thorac Oncol; 2012 Apr; 7(4):631-42. PubMed ID: 22425911
[TBL] [Abstract][Full Text] [Related]
39. Identification of a tumor-suppressive human-specific microRNA within the FHIT tumor-suppressor gene.
Hu B; Ying X; Wang J; Piriyapongsa J; Jordan IK; Sheng J; Yu F; Zhao P; Li Y; Wang H; Ng WL; Hu S; Wang X; Wang C; Zheng X; Li W; Curran WJ; Wang Y
Cancer Res; 2014 Apr; 74(8):2283-94. PubMed ID: 24556720
[TBL] [Abstract][Full Text] [Related]
40. Protoporphyrin IX induces apoptosis in HeLa cells prior to photodynamic treatment.
Bednarz N; Zawacka-Pankau J; Kowalska A
Pharmacol Rep; 2007; 59(4):474-9. PubMed ID: 17901578
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
